Showing results (161-170 of 182) with videos related to
Sort By:
Pageof 19
Journal of the National Cancer Institute|December 21, 2006
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition StudyRowan T Chlebowski, George L Blackburn, Cynthia A Thomson, et al.Histopathology|March 5, 2024
A dedicated structured data set for reporting of invasive carcinoma of the breast in the setting of neoadjuvant therapy: recommendations from the International Collaboration on Cancer Reporting (ICCR)Veerle Bossuyt, Elena Provenzano, W Fraser Symmans, et al.Obesity (Silver Spring, Md.)|December 21, 2021
The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle interventionLinda M Delahanty, Thomas A Wadden, Pamela J Goodwin, et al.The Lancet. Oncology|December 17, 2009
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trialKathy S Albain, William E Barlow, Steven Shak, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancerTiffany A Traina, Hope S Rugo, James F Caravelli, et al.Breast Cancer Research and Treatment|February 21, 2013
PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancerMiguel Martín, Aleix Prat, Alvaro Rodríguez-Lescure, et al.JAMA Oncology|August 21, 2025
Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer: Secondary Analysis of the Breast Cancer Weight Loss (BWEL) TrialJennifer A Ligibel, Karla V Ballman, Linda McCall, et al.Journal of the National Cancer Institute|August 10, 2020
Serial Analysis of Circulating Tumor Cells in Metastatic Breast Cancer Receiving First-Line ChemotherapyMark Jesus M Magbanua, Laura H Hendrix, Terry Hyslop, et al.Breast Cancer Research and Treatment|December 27, 2011
Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Laura J Esserman, Donald A Berry, Maggie C U Cheang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancerHeather L McArthur, Hope Rugo, Benjamin Nulsen, et al.Pageof 19